MicroVention Terumo

MicroVention Terumo

Verified
Catheter-based neuroendovascular technologies for cerebral aneurysms and other neurovascular diseases.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$40—60m (Dealroom.co estimates Sep 2003.)
Aliso Viejo California (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

$0.0

round
N/A

$0.0

round
investor

$0.0

round
investor investor

$0.0

round
investor

$0.0

round
investor

$0.0

round

N/A

Acquisition
Total Funding000k

Recent News about MicroVention Terumo

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.